List of Tables
Table 1. Global Biopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Colony-Stimulating Factor
Table 5. Key Players of Erythropoietin
Table 6. Key Players of Insulin
Table 7. Key Players of Vaccines
Table 8. Key Players of Growth Hormones
Table 9. Key Players of Others
Table 10. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Biopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 12. Global Biopharmaceuticals Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Biopharmaceuticals Market Share by Region (2018-2023)
Table 14. Global Biopharmaceuticals Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 15. Global Biopharmaceuticals Market Share by Region (2024-2029)
Table 16. Biopharmaceuticals Market Trends
Table 17. Biopharmaceuticals Market Drivers
Table 18. Biopharmaceuticals Market Challenges
Table 19. Biopharmaceuticals Market Restraints
Table 20. Global Biopharmaceuticals Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Biopharmaceuticals Market Share by Players (2018-2023)
Table 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceuticals as of 2022)
Table 23. Ranking of Global Top Biopharmaceuticals Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Biopharmaceuticals Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Biopharmaceuticals Product Solution and Service
Table 27. Date of Enter into Biopharmaceuticals Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biopharmaceuticals Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Biopharmaceuticals Revenue Market Share by Type (2018-2023)
Table 31. Global Biopharmaceuticals Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 32. Global Biopharmaceuticals Revenue Market Share by Type (2024-2029)
Table 33. Global Biopharmaceuticals Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Biopharmaceuticals Revenue Market Share by Application (2018-2023)
Table 35. Global Biopharmaceuticals Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 36. Global Biopharmaceuticals Revenue Market Share by Application (2024-2029)
Table 37. North America Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Europe Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 43. Asia-Pacific Biopharmaceuticals Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 44. Asia-Pacific Biopharmaceuticals Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Biopharmaceuticals Market Size by Region (2024-2029) & (US$ Million)
Table 46. Latin America Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Latin America Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 49. Middle East & Africa Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 50. Middle East & Africa Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 52. Roche Company Detail
Table 53. Roche Business Overview
Table 54. Roche Biopharmaceuticals Product
Table 55. Roche Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Amgen Company Detail
Table 58. Amgen Business Overview
Table 59. Amgen Biopharmaceuticals Product
Table 60. Amgen Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 61. Amgen Recent Development
Table 62. AbbVie Company Detail
Table 63. AbbVie Business Overview
Table 64. AbbVie Biopharmaceuticals Product
Table 65. AbbVie Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Sanofi-Aventis Company Detail
Table 68. Sanofi-Aventis Business Overview
Table 69. Sanofi-Aventis Biopharmaceuticals Product
Table 70. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 71. Sanofi-Aventis Recent Development
Table 72. Johnson & Johnson Company Detail
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Biopharmaceuticals Product
Table 75. Johnson & Johnson Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Pfizer Company Detail
Table 78. Pfizer Business Overview
Table 79. Pfizer Biopharmaceuticals Product
Table 80. Pfizer Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Novo Nordisk Company Detail
Table 83. Novo Nordisk Business Overview
Table 84. Novo Nordisk Biopharmaceuticals Product
Table 85. Novo Nordisk Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 86. Novo Nordisk Recent Development
Table 87. Eli Lilly Company Detail
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Biopharmaceuticals Product
Table 90. Eli Lilly Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 91. Eli Lilly Recent Development
Table 92. Novartis Company Detail
Table 93. Novartis Business Overview
Table 94. Novartis Biopharmaceuticals Product
Table 95. Novartis Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck Biopharmaceuticals Product
Table 100. Merck Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Sun Company Detail
Table 103. Sun Business Overview
Table 104. Sun Biopharmaceuticals Product
Table 105. Sun Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 106. Sun Recent Development
Table 107. 3sbio Company Detail
Table 108. 3sbio Business Overview
Table 109. 3sbio Biopharmaceuticals Product
Table 110. 3sbio Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 111. 3sbio Recent Development
Table 112. Changchun High Tech Company Detail
Table 113. Changchun High Tech Business Overview
Table 114. Changchun High Tech Biopharmaceuticals Product
Table 115. Changchun High Tech Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 116. Changchun High Tech Recent Development
Table 117. CP Guojian Company Detail
Table 118. CP Guojian Business Overview
Table 119. CP Guojian Biopharmaceuticals Product
Table 120. CP Guojian Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 121. CP Guojian Recent Development
Table 122. Biotech Company Detail
Table 123. Biotech Business Overview
Table 124. Biotech Biopharmaceuticals Product
Table 125. Biotech Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 126. Biotech Recent Development
Table 127. Gelgen Company Detail
Table 128. Gelgen Business Overview
Table 129. Gelgen Biopharmaceuticals Product
Table 130. Gelgen Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 131. Gelgen Recent Development
Table 132. Innovent Company Detail
Table 133. Innovent Business Overview
Table 134. Innovent Biopharmaceuticals Product
Table 135. Innovent Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 136. Innovent Recent Development
Table 137. Dong Bao Company Detail
Table 138. Dong Bao Business Overview
Table 139. Dong Bao Biopharmaceuticals Product
Table 140. Dong Bao Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 141. Dong Bao Recent Development
Table 142. Ganlee Company Detail
Table 143. Ganlee Business Overview
Table 144. Ganlee Biopharmaceuticals Product
Table 145. Ganlee Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 146. Ganlee Recent Development
Table 147. United Laboratories Company Detail
Table 148. United Laboratories Business Overview
Table 149. United Laboratories Biopharmaceuticals Product
Table 150. United Laboratories Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 151. United Laboratories Recent Development
Table 152. SANDOZ (NOVARTIS) Company Detail
Table 153. SANDOZ (NOVARTIS) Business Overview
Table 154. SANDOZ (NOVARTIS) Biopharmaceuticals Product
Table 155. SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 156. SANDOZ (NOVARTIS) Recent Development
Table 157. Teva Pharmaceutical Company Detail
Table 158. Teva Pharmaceutical Business Overview
Table 159. Teva Pharmaceutical Biopharmaceuticals Product
Table 160. Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 161. Teva Pharmaceutical Recent Development
Table 162. Hospira （Pfizer） Company Detail
Table 163. Hospira （Pfizer） Business Overview
Table 164. Hospira （Pfizer） Biopharmaceuticals Product
Table 165. Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 166. Hospira （Pfizer） Recent Development
Table 167. MYLAN Company Detail
Table 168. MYLAN Business Overview
Table 169. MYLAN Biopharmaceuticals Product
Table 170. MYLAN Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 171. MYLAN Recent Development
Table 172. Sun pharma Company Detail
Table 173. Sun pharma Business Overview
Table 174. Sun pharma Biopharmaceuticals Product
Table 175. Sun pharma Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
Table 176. Sun pharma Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceuticals Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Biopharmaceuticals Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Interferon Features
Figure 5. Colony-Stimulating Factor Features
Figure 6. Erythropoietin Features
Figure 7. Insulin Features
Figure 8. Vaccines Features
Figure 9. Growth Hormones Features
Figure 10. Others Features
Figure 11. Global Biopharmaceuticals Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 12. Global Biopharmaceuticals Market Share by Application: 2022 VS 2029
Figure 13. Tumor Case Studies
Figure 14. Diabetes Case Studies
Figure 15. Cardiovascular Case Studies
Figure 16. Hemophilia Case Studies
Figure 17. Others Case Studies
Figure 18. Biopharmaceuticals Report Years Considered
Figure 19. Global Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Biopharmaceuticals Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Biopharmaceuticals Market Share by Region: 2022 VS 2029
Figure 22. Global Biopharmaceuticals Market Share by Players in 2022
Figure 23. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceuticals as of 2022)
Figure 24. The Top 10 and 5 Players Market Share by Biopharmaceuticals Revenue in 2022
Figure 25. North America Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Biopharmaceuticals Market Share by Country (2018-2029)
Figure 27. United States Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Biopharmaceuticals Market Share by Country (2018-2029)
Figure 31. Germany Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Biopharmaceuticals Market Share by Region (2018-2029)
Figure 39. China Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Japan Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Biopharmaceuticals Market Share by Country (2018-2029)
Figure 47. Mexico Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Brazil Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Biopharmaceuticals Market Share by Country (2018-2029)
Figure 51. Turkey Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Roche Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 54. Amgen Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 55. AbbVie Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 56. Sanofi-Aventis Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 59. Novo Nordisk Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 60. Eli Lilly Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 61. Novartis Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 62. Merck Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 63. Sun Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 64. 3sbio Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 65. Changchun High Tech Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 66. CP Guojian Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 67. Biotech Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 68. Gelgen Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 69. Innovent Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 70. Dong Bao Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 71. Ganlee Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 72. United Laboratories Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 73. SANDOZ (NOVARTIS) Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 74. Teva Pharmaceutical Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 75. Hospira （Pfizer） Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 76. MYLAN Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 77. Sun pharma Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
